The inquiry centers around the importation process of Human Immunoglobulin, a critical medical component. The CID is scrutinizing the circumstances and protocols surrounding the importation, aiming to ascertain any irregularities or potential violations of regulations.
Senior officials, including the Deputy Secretary of the Treasury, the Chairman of the State Pharmaceutical Corporation, and the Director General of Health, have also been approached regarding the importation of Human Immunoglobulin.
Statements are currently being recorded from the Deputy Secretary of the Treasury as part of an ongoing process led by the Criminal Investigation Department (CID). The investigation aims to scrutinize the importation process of Human Immunoglobulin, an essential medical component, to ensure compliance with regulations and identify any potential irregularities.
As the investigation progresses, more details are expected to emerge, providing clarity on the circumstances surrounding the importation of Human Immunoglobulin and the role of Finance Ministry officials in the process.